New botulinum neurotoxin constructs for treatment of chronic pain (2023)
Attributed to:
Long-term consequences of silencing pain pathways with novel Botulinum constructs.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.26508/lsa.202201631
PubMed Identifier: 37041008
Publication URI: http://europepmc.org/abstract/MED/37041008
Type: Journal Article/Review
Parent Publication: Life Science Alliance
Issue: 6